NEKTAR THERAPEUTICS Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | D | 0.00 | 1,250 | 0 | 13,750 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 11.92 | 556 | 6,628 | 694 | 1.3 K to 694 (-44.48 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | D | 0.00 | 2,166 | 0 | 23,834 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 11.92 | 963 | 11,479 | 76,319 | 77.3 K to 76.3 K (-1.25 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 0.00 | 2,166 | 0 | 77,282 | 75.1 K to 77.3 K (+2.88 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | D | 0.00 | 5,625 | 1 | 61,875 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 11.92 | 2,147 | 25,592 | 13,478 | 15.6 K to 13.5 K (-13.74 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 0.00 | 5,625 | 1 | 15,625 | 10 K to 15.6 K (+56.25 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | D | 0.00 | 875 | 0 | 9,625 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 11.92 | 390 | 4,649 | 485 | 875 to 485 (-44.57 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 0.00 | 875 | 0 | 875 | 0 to 875 |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | D | 0.00 | 1,875 | 0 | 20,625 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 11.92 | 716 | 8,535 | 5,158 | 5.9 K to 5.2 K (-12.19 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 0.00 | 1,875 | 0 | 5,874 | 4 K to 5.9 K (+46.89 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | D | 0.00 | 2,166 | 0 | 23,834 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 11.92 | 827 | 9,858 | 6,590 | 7.4 K to 6.6 K (-11.15 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 0.00 | 2,166 | 0 | 7,417 | 5.3 K to 7.4 K (+41.25 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | D | 0.00 | 2,166 | 0 | 23,834 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 11.92 | 963 | 11,479 | 5,803 | 6.8 K to 5.8 K (-14.23 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 0.00 | 2,166 | 0 | 6,766 | 4.6 K to 6.8 K (+47.09 %) |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,666 | 75,362 | 0 | |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 11.49 | 11,666 | 134,042 | 5,251 | 16.9 K to 5.3 K (-68.96 %) |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,666 | 75,362 | 16,917 | 5.3 K to 16.9 K (+222.17 %) |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 15,000 | |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 11.49 | 15,000 | 172,350 | 3,999 | 19 K to 4 K (-78.95 %) |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 18,999 | 4 K to 19 K (+375.09 %) |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.46 | 66,666 | 430,662 | 0 | |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 11.49 | 66,666 | 765,992 | 10,000 | 76.7 K to 10 K (-86.96 %) |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.46 | 66,666 | 430,662 | 76,666 | 10 K to 76.7 K (+666.66 %) |
| Feb 05 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 12.21 | 100,000 | 1,221,000 | 100,000 |